Zephyrx to Integrate Niox FeNO
Zephyrx will integrate FeNO by Niox into the Zephyrx Respiratory Cloud Platform to advance clinical research, according to a joint press release.
Zephyrx will integrate FeNO by Niox into the Zephyrx Respiratory Cloud Platform to advance clinical research, according to a joint press release.
High peripheral eosinophil counts could help identify patients with COPD and eosinophilic inflammation, irrespective of asthma history, according to new research.
Aetna has updated its Exhaled Breath Tests Clinical Policy to include the measurement of exhaled nitric oxide (FeNO) as “medically necessary” for the evaluation of asthma.
A challenge test performed on sensitized patients determines whether various allergens and irritants cause an increase in exhaled nitric-oxide.
Read More